CONTACT US
Report Tuesday, October 13
October 13, 2020
Information from Press Conferences and Official Media
Federal Information
(October 13, 2020)
Secretary of Foreign Affairs
- During the morning conference, an agreement has been signed to provide access to 77.4 million doses of COVID-19 vaccine for Mexico between the end of the year and the middle of next year. vaccine for Mexico between the end of this year and the middle of next year.
- This agreement has been made with the company AstraZeneca, with whom an agreement had already been made for the production and distribution of its vaccine in Mexican and Argentine laboratories. and distribution of its vaccine in Mexican and Argentine laboratories.
- An agreement has also been signed with Pfizer so that between December 2020 and 2021, Mexico will have access to between 15.5 and 34.4 million doses of its vaccine, depending on what the health sector deems best. 15.5 and 34.4 million doses of its vaccine, depending on what the health sector deems best, according to Foreign Minister Ebrard. Ebrard.
- The signing of another agreement was announced, but with the Asian company CanSino, for 35 million test doses to be carried out during Phase 3 of its vaccine in Mexico. Phase 3 of its vaccine in Mexico.
- The Chancellor reiterated that all these vaccines are in addition to those to be obtained through the COVAX mechanism.
- He reiterated that Phase 3 vaccines from the USA, Russia, Germany, France and Italy are currently scheduled to be tested in Mexico, in addition to the recently announced vaccine from China, France and Italy, in addition to the recently announced vaccine from China.
Secretary of Finance and Public Credit
- So far, an investment of 1,659 million dollars is foreseen, to access 116.69 million doses of vaccines, represented by all the previously announced vaccines.
- By the end of this year, total advances of 6,812 million pesos will have been made to Pfizer, CanSino, AstraZeneca and the the COVAX mechanism.
Number of cases


Economic Situation
Financial indicators

Main economic news
(October 13, 2020)
- Formal employment 'shouts out' in September: 113,850 jobs increase jobs. This is the second consecutive month with positive data on formal jobs (El Financiero). jobs (El Financiero). https://bit.ly/36ZYx6Y
- IMF adjusts forecast for Mexico's economy in 2020; expects contraction of 9%, up from 10.5%. of 9%, up from 10.5%. The International Monetary Fund also adjusted its forecast for forecast for the country in 2021 (El Financiero). https://bit.ly/2GT0kQG
- SHCP: 20,000 million pesos would be lost due to changes in STPS on alcoholic beverages. The The Treasury would stop collecting these resources by changing the ad valoren tax for ad quantum (El Economista). ad quantum (El Economista). https://bit.ly/2GYgWpO
World News

- Boris Johnson proposes pub closures in parts of England due to Covid-19 outbreaks Covid-19 outbreaks. Johnson announced the three-tier system is an attempt to standardize a patchwork of often complicated and confusing to standardize a patchwork of often complicated and confusing restrictions imposed across England. imposed across England. MPs must now put the proposal to a vote. vote on the proposal. https://bit.ly/34VTamu
- COVID-19 soars in Republican states as Trump returns to the campaign trail. campaign. With three weeks until Election Day, COVD19's advance through the Midwest and West is hitting several Republican strongholds and the key swing state of Wisconsin. Republican strongholds and the key swing state of Wisconsin. https://bit.ly/3lJRe7M
- Johnson & Johnson suspends COVID-19 vaccine trials after illness in a volunteer. illness in a volunteer. Johnson & Johnson reported that its study of the COVID-19 vaccine study was temporarily halted due to an unexplained illness in a trial participant. unexplained illness in a trial participant. Jake Sargent, spokesman for New Brunswick, N.J.-based company, confirmed that the study was on pause. paused. https://bit.ly/2FojJrR